2015臺大攝護祭-醫藥護人員場 | 臺大泌尿部/臺灣楓城泌尿學會

管理者：未設定

1.
29:53

Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer—Why, When, and How?
2.
32:21

Bone‐Targeting Agents in Prostate Cancer Care– One Thing That is Underrated in Taiwan
3.
35:51

Sequential and Combination Therapy for mCRPC – What Do We Have and How Do We Apply?
4.
24:06

How Low Should Plasma Testosterone Level Be in the Treatment of Metastatic Prostate Cancer? ‐New Inspiration from Next Generation Hormonal Agents
5.
38:19

Active Surveillance or Watchful Waiting – How do They Apply to Your Patients?
6.
27:24

Radiotherapy from within The Bone For Patients with Metastatic Castration‐Resistant Prostate Cancer (mCRPC)
7.
35:40

Dissecting Lower Urinary Tract Symptoms–Pathophysiological and Pharmacological Perspectives
8.
38:16

Reappraisal of Published Randomized LUTS/BPH Clinical Trials–What Have We Learned and Where Do We Stand?
9.
15:48

Overactive Bladder and Urge Incontinence In Men: Current Oopinions, Medical and Surgical Management
10.
33:11

Nocturia and Nocturnal Enuresis
11.
45:03

Laser or Bipolar Enucleation of The Prostate